Extended limb stasis in the encore tissue preservation device

Vascular Perfusion Solutions Inc. received an $818,337 Project Grant award dated August 15, 2025, from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports research and development of extended limb stasis capabilities within the ENCORE Tissue Preservation Device, with performance through August 14, 2027, at the awardee's San Antonio, Texas facility. This modification to the existing award corrected administrative contact information and updated specific terms and conditions within sections A.4, A.5II, A.6, and B.3.

The Military Medical Research and Development program funds biomedical research initiatives designed to transform healthcare for military service members and the American public through innovative solutions addressing military-relevant medical challenges. Under this mechanism, the ENCORE device research aims to advance tissue preservation and perfusion technologies, which have applications for trauma care and medical interventions relevant to military and civilian populations. Awards under this CFDA typically range from $100,000 to $20 million and support projects with performance periods averaging three to four years.